Articles

January 22, 2019: Study Supports Patient Testimony Against Electroshock
By CCHR International
In May 2006, Harold Robertson and Robin Pryor writing in BJPsych, “Memory and cognitive effects of ECT: informing and assessing patients,” determined: “Data do not exist at this time to confirm the mechanisms by which ECT exerts its adverse effects.” Read More >>

January 15, 2019: FDA Colludes with APA to Keep Dangerous ECT Device on the Market
By CCHR International
It is clear that the Food and Drug Administration (FDA) and American Psychiatric Association (APA) members know that the ECT device manufacturers are not going to conduct research while at the same time, don’t want the device taken off the market. FDA was and is only looking for “mitigating” circumstances to keep the shock device on the market without clinical trials supporting the devices’ safety—and is doing this, despite the ongoing risk to patients. Read More >>

January 11, 2019: A Message to the FDA: ECT Produces Brain Damage
By CCHR International
The U.S. Food and Drug Administration (FDA) undermines the scores of studies and patient testimonies that indicate ECT causes brain damage. Dr. Lawrence Park, the FDA Medical Officer, who wrote the Executive Summary on ECT for the FDA [in 2010] is a psychiatrist who has co-authored numerous studies on ECT. Read More >>

January 4, 2019: UN Calls for Ban on Non-Consenting “Medical” Interventions & State Condoned ECT Torture
By CCHR International
In 2013, Kathleen Lynch, Minister of State for Disability, Equality, Mental Health and Older People in Ireland stated that Ireland’s mental health law “will be changed so that unwilling patients will no longer be forced to receive ECT.” This aligned with the February 16, 2013, United Nations Special Rapporteur on Torture and Other Cruel Inhuman or Degrading Treatment or Punishment report. Read More >>

December 19, 2018: Psychiatrists Dismiss Patient Evidence Against ECT as “Anecdotal” to Protect Profits
By Jan Eastgate, President CCHR International
In 2015, the U.S. Food and Drug Administration issued its “Neurological Devices; Reclassification of Electroconvulsive Therapy Devices Intended for Use in Treating,” recommending that the ECT device be rated Class II (less risk classification than its current Class III). Read More >>

December 17, 2018: Conflicts of Interest Regarding ECT Covers Up Damage
By CCHR International
The Food and Drug Administration (FDA) Proposal in 2015 to reduce the risk classification of the ECT device instead of banning it, is of enormous concern, because of potential conflicts of interest of those it is relying upon. Read More >>

December 7, 2018: Electroshock: Lawsuits and Death Findings
By CCHR International
The long-term damaging effects of ECT has led to wrongful death lawsuits, as well as other grounds for law suits, including assault and battery and ECT causing personal injury, including brain damage and memory loss.  Read More >>

November 21, 2018: Electroshocked at Age 13—My Personal Horror Story
By L. J. Wilde
It was fall 1968. I was 13 years old and very unhappy with my family life. The only way I knew how to get attention and help was take an overdose of my stepmother’s Valium. But, no one ever bothered to ask me what was going on or why I did it. I was just a kid. Read More >>

October 30, 2018: An ECT Survivor Speaks Out—Psychiatrist Claimed Damage from ECT was Due to an Underlying Mental Disorder
By Julie Greene
The one thing I wanted to do, when it was all over, was to tell my story. I wasn’t sure what the story was, because I didn’t know, even when I put pen to paper, that ECT had caused the mysterious “illness” that had suddenly befallen me in 1996, when I was 39 years old. Read More >>